RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--With the biopharmaceutical industry currently balanced atop tectonic plates, industry leaders must not settle on incremental innovation, but should look toward Asia as a unique opportunity for “radical transformation,” according to a paper from Quintiles, which says the need, the know-how, the resources and the will for innovation are all present in Asia.
